Table 3.
Renal cystic, interstitial and tumorous kidney diseases. (The leading diagnostic features are renal ultrasound findings of cysts, increased echogenicity, or tumor, respectively).
| CYSTIC, INTERSTITIAL AND TUMOROUS KIDNEY DISEASES | OMIM No. | MOI | Characteristic signs and features | Gene symbol(s), gene product(s) |
|---|---|---|---|---|
| ADPKD, type 1 | #601313 | AD | Polycystic kidneys, liver cysts, brain aneurysms, CKD | PKD1, polycystin 1 |
| ADPKD, type 2 | #173910 | AD | Polycystic kidneys, CKD | PKD2, polycystin 2 |
| ARPKD | #263200 | AR | Polycystic kidneys, liver fibrosis, CKD | PKHD1, fibrocystin/polyductin |
| Nephronophthisis types 1–9 | #256100 | AR | Polyuria, polydipsia, anemia, CKD | NPHP1-NPHP9, nephrocystin 1–9 |
| Medullary cystic kidney disease | #174000 | AD | Adult onset CKD, hyperuricemia, FJHN | UMOD, Tamm-Horsfall protein |
| Meckel-Gruber syndrome (MKS) | #249000 #607361 |
AR | Polycystic kidneys, multiple organ dysplasia, perinatal lethal | MKS1; MKS3, meckelin (also allelic with NPHP genes) |
| Bardet-Biedl syndrome types 1–12 | #209900 | AR | Retinitis pigmentosa, polydactyly, MR, hypogenitalism and obesity | BBS1-BBS12, BBS proteins |
| Tuberous sclerosis types 1 and 2 | #191100 #191092 |
AD | Renal angiomyolipomas, skin changes, seizures |
TSC1, hamartin TSC2, tuberin |
| von-Hippel-Lindau disease | #193300 | AD | Lindau tumor, retinal angiomatosis, pheochromocytoma, renal tumor | VHL, Tumor suppressor gene g7 |
| Wilms-tumor-aniridia syndrome | #194072 | AD | Wilms tumour, aniridia, growth retardation | WT1, WT suppressor gene |
| Papillary renal cell carcinoma | #164860 | AD | Papillary renal cell carcinoma | MET gene, protooncogen |
ADPKD=autosomal dominant polycystic kidney disease, AD=autosomal dominant, AR=autosomal recessive, CNV=central nervous system, FJHN=familial juvenile hyperuricemic nephropathy, MR=mental retardation, XR=X-linked recessive